Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease
Chronic kidney disease (CKD) is defined by a low glomerular filtration rate or high
albuminuria, and affects 15–20% of adults globally. CKD increases the risk of various …
albuminuria, and affects 15–20% of adults globally. CKD increases the risk of various …
Interventions to attenuate vascular calcification progression in chronic kidney disease: a systematic review of clinical trials
C Xu, ER Smith, MK Tiong, I Ruderman… - Journal of the …, 2022 - journals.lww.com
Interventions To Attenuate Vascular Calcification Progressio... : Journal of the American
Society of Nephrology Interventions To Attenuate Vascular Calcification Progression in Chronic …
Society of Nephrology Interventions To Attenuate Vascular Calcification Progression in Chronic …
Circulating extracellular vesicle-propagated microRNA signature as a vascular calcification factor in chronic kidney disease
T Koide, S Mandai, R Kitaoka, H Matsuki… - Circulation …, 2023 - Am Heart Assoc
Background: Chronic kidney disease (CKD) accelerates vascular calcification via
phenotypic switching of vascular smooth muscle cells (VSMCs). We investigated the roles of …
phenotypic switching of vascular smooth muscle cells (VSMCs). We investigated the roles of …
Plant-dominant low protein diet: A potential alternative dietary practice for patients with chronic kidney disease
Y Sakaguchi, JY Kaimori, Y Isaka - Nutrients, 2023 - mdpi.com
Dietary protein restriction has long been a cornerstone of nutritional therapy for patients with
chronic kidney diseases (CKD). However, the recommended amount of dietary protein …
chronic kidney diseases (CKD). However, the recommended amount of dietary protein …
Recommended calcium intake in adults and children with chronic kidney disease—a European consensus statement
P Evenepoel, HS Jørgensen, J Bover… - Nephrology Dialysis …, 2024 - academic.oup.com
Mineral and bone disorders (MBD) are common in patients with chronic kidney disease
(CKD), contributing to significant morbidity and mortality. For several decades, the first-line …
(CKD), contributing to significant morbidity and mortality. For several decades, the first-line …
Progress in pharmacotherapy for the treatment of hyperphosphatemia in renal failure
V Cernaro, E Longhitano, V Calabrese… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction Among the clinical and metabolic complications of progressive chronic kidney
disease (CKD), CKD-mineral bone disorder (CKD-MBD) significantly contributes to morbidity …
disease (CKD), CKD-mineral bone disorder (CKD-MBD) significantly contributes to morbidity …
[HTML][HTML] Regulatory effects of nutritional and metabolic disorders on vascular calcification in chronic kidney disease: a narrative review
Y Xiong, Y Yu, B Su - Annals of Translational Medicine, 2023 - ncbi.nlm.nih.gov
Methods Electronic databases (PubMed, Embase, and the Cochrane Central Register of
Controlled Trials) were searched from 2001 as at July 26, 2022, to select and summarize the …
Controlled Trials) were searched from 2001 as at July 26, 2022, to select and summarize the …
Cutting back on low-value health care practices supports sustainable kidney care
S McAlister, VA Luyckx, AK Viecelli - Kidney International, 2024 - Elsevier
July 2023 marked the hottest month on record, underscoring the urgent need for action on
climate change. The imperative to reduce carbon emissions extends to all sectors, including …
climate change. The imperative to reduce carbon emissions extends to all sectors, including …
The Bone-Vascular Axis in Chronic Kidney Disease: From Pathophysiology to Treatment
C Vachey, A Candellier, S Toutain… - Current Osteoporosis …, 2024 - Springer
The Bone-Vascular Axis in Chronic Kidney Disease: From Pathophysiology to Treatment |
Current Osteoporosis Reports Skip to main content SpringerLink Account Menu Find a journal …
Current Osteoporosis Reports Skip to main content SpringerLink Account Menu Find a journal …
Effects of iron-based phosphate binders on mortality and cardiovascular events in patients receiving maintenance dialysis
Phosphate binders are the main treatment for hyperphosphatemia in patients with chronic
kidney disease, and iron-based phosphate binders have been used with increasing …
kidney disease, and iron-based phosphate binders have been used with increasing …